| Net Cash Provided by (Used in) Operating Activities |
$2,253,158 |
USD |
-5.5% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$3,689,879 |
USD |
-308% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,254,379 |
USD |
84% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
7,788,922 |
shares |
0.52% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$182,342 |
USD |
-108% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$295,966 |
USD |
-4.3% |
Q4 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,001,956 |
USD |
-166% |
Q4 2025 |
FY 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$411,525 |
USD |
-859% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$23,002,201 |
USD |
0.16% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$4,489,170 |
USD |
-9.2% |
Q4 2025 |
FY 2025 |